| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 673191 | Null | 0.0252510646170347 | 0.20549771 |
| NSC 674071 | Null | 0.0252510646170347 | -0.030496388 |
| NSC 677003 | Null | 0.0252510646170347 | -0.19646801 |
| NSC 678994 | 2-Butenedioic acid, 2-(6-aminopurin-9-yl)-, diethylester, (E)- | 0.0252510646170347 | 0.055942358 |
| NSC 682094 | Quinolinium, 1,1'-(1,10-decanediyl)bis[(2-methyl- 4-(phenylmethylamino)-, diperchlorate | 0.0252510646170347 | 0.11648104 |
| NSC 692655 | D-Homo-17a-aza-5-androsteno[17,16-c]pyrazol-3-yl,2'-(4-fluorophenyl)-, acetate | 0.0252510646170347 | 0.10572744 |
| NSC 704213 | Methanesulfonamide, N-[3-methyl-7-(phenylmethoxy)-1-(phenylsulfonyl)- 1H-indol-5-yl]- | 0.0252510646170347 | 0.084392133 |
| NSC 717696 | Oligomycin C | 0.0252510646170347 | -0.036900141 |
| NSC 728028 | 1 - Ethyl -6 - (Ethylthio) - 1H - pyrazolo[3,4-d]pyrimidin - 4 - amine | 0.0252510646170347 | 0.22819143 |
| NSC 338304 | Iron, dichloro[hexahydro-1H-azepine-1-carbothioic acid [1-(2-pyridinyl)ethylidene]hydraziato] | 0.0252562667234373 | 0.17673709 |